Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:14.71em"/><col style="width:11.18em"/><col style="width:10.88em"/><col style="width:4.32em"/></colgroup><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">High-CXCR3 expression</td><td class="align_center">Low-CXCR3 expression</td><td class="align_center"><i>P</i>-value</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Gastric cancerous tissue (n = 156)</td><td class="align_center">59 (37.82%)</td><td class="align_center">97 (62.18%)</td><td class="align_center" rowspan="2"><i>0.001</i></td></tr><tr><td class="align_left">Paracancerous tissue (n = 156)</td><td class="align_center">26 (16.67%)</td><td class="align_center">130 (83.33%)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The expression of CXCR3 protein in gastric cancer and paracancerous tissues.</div>

BioMed Research International

tab1

Table 1

Table 1: Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer 